What to expect: You may be more sensitive to digestive side effects at first
The responsible takeaway is that topical GHK-Cu has a reassuring but not exhaustively proven safety record, while systemic use is genuinely under-studied in humans
Geoff Geredien (00:29:57): Yeah, I think agreed all round in terms of the wide range of employer sizes that we've seen adopting for us probably the smallest group around 25 employees, but typically it's going to be again, in connection with the delivery of a wellness program for those size groups, not necessarily just a standalone LSA benefit
Lower doses mean less appetite suppression, which means food choices become even more consequential for weight management outcomes
Gut microbiota disturbances are also implicated in nutrient metabolism dysregulation
Short-chain fatty acids, particularly butyrate and propionate, have been shown to activate receptors on enteroendocrine L-cells, triggering GLP-1 release